West Pharma: Still A Buy, But Expectations Are Rising
West Pharmaceutical Services’ GLP-1 demand, HVP upgrades and Annex 1 conversions support double-digit growth, but its premium valuation…
NYSE
WST
1 story
$26B Market cap · 2026-10-08
West Pharmaceutical Services’ GLP-1 demand, HVP upgrades and Annex 1 conversions support double-digit growth, but its premium valuation…
Letters that discuss WST.